Navigation Links
Cocoa extract may counter specific mechanisms of Alzheimer's disease
Date:6/23/2014

(NEW YORK June 23) A specific preparation of cocoa-extract called Lavado may reduce damage to nerve pathways seen in Alzheimer's disease patients' brains long before they develop symptoms, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published June 20 in the Journal of Alzheimer's Disease (JAD).

Specifically, the study results, using mice genetically engineered to mimic Alzheimer's disease, suggest that Lavado cocoa extract prevents the protein β-amyloid- (Aβ) from gradually forming sticky clumps in the brain, which are known to damage nerve cells as Alzheimer's disease progresses.

Lavado cocoa is primarily composed of polyphenols, antioxidants also found in fruits and vegetables, with past studies suggesting that they prevent degenerative diseases of the brain.

The Mount Sinai study results revolve around synapses, the gaps between nerve cells. Within healthy nerve pathways, each nerve cell sends an electric pulse down itself until it reaches a synapse where it triggers the release of chemicals called neurotransmitters that float across the gap and cause the downstream nerve cell to "fire" and pass on the message.

The disease-causing formation of Aβ oligomers groups of molecules loosely attracted to each other build up around synapses. The theory is that these sticky clumps physically interfere with synaptic structures and disrupt mechanisms that maintain memory circuits' fitness. In addition, Aβ triggers immune inflammatory responses, like an infection, bringing an on a rush of chemicals and cells meant to destroy invaders but that damage our own cells instead.

"Our data suggest that Lavado cocoa extract prevents the abnormal formation of Aβ into clumped oligomeric structures, to prevent synaptic insult and eventually cognitive decline," says lead investigator Giulio Maria Pasinetti, MD, PhD, Saunders Family Chair and Professor
'/>"/>

Contact: Elizabeth Dowling
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. (Sakai, Japan Xocai Cocoa Cosmeceutical News Update): Xophoria "Ripped and Rich" MLM #1 Lip Plump Program Gains Fame in Hyogo and Hiroshima
2. (Sendai Japan MXI Corp Cocoa "Personal Care" Update): Xophoria "Ripped and Rich" MLM Hair Shampoo Program Gains Notoriety in Takatsuki and Takarazuka
3. (Saitama, Japan MXI Corp Cocoa "Weight Loss" Update): Xophoria "Ripped and Rich" MLM Body Wash Program Gains Popularity in Wakayama and Chigasaki
4. Defense Nutrition Introduces CoCoMadness™ the First All Natural Cocoa Energy Chewable
5. Cocoa and Drinking Chocolate Production in the US Industry Market Research Report Now Available from IBISWorld
6. InVite® Health Introduces New and Improved Antioxidant Product – Cocoa Tx™
7. Pure Cocoa Powder, the Key Ingredient in Dark Chocolate and Found in Diabetes Support Supplements has been Clinically Proven to Reduce Cardiovascular Risk
8. First validated method for analyzing flavanols and procyanidins in cocoa products could help scientists and the industry in standardized reporting
9. Geranium extracts inhibit HIV-1
10. Satiereal Saffron Extract Review - The Natural Appetite Suppressant Supplement is Now Available for Sale With Extra Discount Offer as New Year Special
11. Dr. Oz Graviola Extract - The Natural Health Supplement is Now Available for Sale With Extra Discount Offer as New Year Special
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Illinois (PRWEB) September 02, 2014 ... Chief Executive Officer and Chief Information Officer Strategy ... Carlton Chicago. , Becker's Hospital Review Chief Executive ... together hospital and health system Chief Executive Officers, ... hospital and health system executives through high-quality ...
(Date:9/2/2014)... 2014 Recently, BambooIndustry.com, an excellent company ... of strand woven bamboo floors to celebrate ... show its appreciation to the frequent callers, BambooIndustry.com launched ... In addition to strand woven floors, BambooIndustry.com provides many ... scraped floors, click strand woven floors, click lock floors, ...
(Date:9/2/2014)... 2, 2014 4 pm EDT): In a Viewpoint published ... Association , a team of Boston researchers call for ... quality in the United States. The researchers from the ... University, Harvard University and Boston Children,s Hospital write that ... foods could both help people make meaningful dietary changes ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 TCG, a leading ... Inc. 5000 as one of the fastest-growing companies in America ... time total. TCG was previously recognized in 2013, 2012, 2011, ... TCG’s revenue has grown 86% from 2010 to 2013, ranking ... fastest growing businesses in America - up 635 spots from ...
(Date:9/2/2014)... 02, 2014 The use of Xarelto ... is growing at a rapid pace, even as ... courts around the U.S., Bernstein Liebhard LLP reports. According ... Medicine, within a year of its 2011 launch, patients ... warfarin, a blood thinner that has been in use ...
Breaking Medicine News(10 mins):Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 2Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 3Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 4Health News:Cheap Strand Woven Bamboo Floors For Autumn On Sale At BambooIndustry.com 2Health News:Taxes and subsidies could encourage healthier diet and lower healthcare costs 2Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 3Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 4
... College of Nursing (NYUCN) received a five-year, $7.56 million grant ... National Institutes of Health (NIH) to evaluate the efficacy and ... high risk for HIV in their communities, test them for ... if they are found to be HIV infected. An ...
... -- A new study on living kidney donation finds ... to their recipients than white donors are. Understanding ... organ donation and assist in the development of specialized ... Wake Forest Baptist Medical Center, in Winston-Salem, N.C. ...
... cure, and one that affects all age groups. NMC is ... and a half months after diagnosis, making the development of ... difficult, to say the least. But difficult doesn,t mean ... the University of Notre Dame, is one of a group ...
... Science and its partners today launched a report on ... European innovation stakeholders to give their views on the ... the EC Green Paper "From Challenges to Opportunities: Towards ... Funding". It expands on the question of strengthening women,s ...
... newest participants in the Hartford Doctoral Fellows Program in ... John A. Hartford Foundation , administered by The ... Lubben , DSW, MPH. Each fellow receives a $50,000 ... her home institution, which enables the recipient to more fully ...
... , FRIDAY, Oct. 28 (HealthDay News) -- Preschool students ... they,re placed in a classroom with higher-achieving children, compared ... say. The findings are important because many preschool ... children, whose development of language skills may be lagging, ...
Cached Medicine News:Health News:NYUCN receives $7.56 million NIH grant to research heterosexuals at high risk of HIV infection 2Health News:NYUCN receives $7.56 million NIH grant to research heterosexuals at high risk of HIV infection 3Health News:NYUCN receives $7.56 million NIH grant to research heterosexuals at high risk of HIV infection 4Health News:Black Kidney Donors More Likely to Be Related to Recipients 2Health News:Controlling gene expression to halt cancer growth 2Health News:Shaping a new culture of research & innovation in Europe 2Health News:Prestigious Hartford grants bolster awardees' social work research 2Health News:Prestigious Hartford grants bolster awardees' social work research 3Health News:Preschool Peers May Boost Language Skills in Kids 2
(Date:9/2/2014)... , Spanje, September 2, 2014 ... GARFIELD AF Registry bij het ESC CONGRESS ... bij patiënten met risico op beroerte in ... Gegevens van bijna 12.500 patiënten ingeschreven ... FIELD-Atrial Fibrillation (GARFIELD-AF), een innovatief, onafhankelijk initiatief ...
(Date:9/2/2014)... , September 2, 2014 ... ESC CONGRESS 2014 provide insight into treatment and ... everyday clinical practice --   Data ... Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF), an ... stroke prevention strategies for atrial fibrillation (AF) patients ...
(Date:9/2/2014)... -- , Registry provides new insights into ... treatment satisfaction [ 1 ] , ...        (Photo: http://photos.prnewswire.com/prnh/20140902/703596 ) ... Barcelona, Spain : Daiichi Sankyo today announced ... Registry in Atrial Fibrillation (PREFER in AF), revealing significant ...
Breaking Medicine Technology:Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 2Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 3Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 4Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 5Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 6Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 7Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 8Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 9Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 10Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 3Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 4Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 5Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 6Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 7Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 8Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 9One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 2One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 3One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 4One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 5One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 6One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 7One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 8
... 2011 Curemark, LLC , a drug research ... diseases, announced today that its compound CM-182 demonstrated positive ... amphetamines. The mouse model screening was performed by the ... indicated that the amphetamine-injected C57BL/6 mice exhibited a dose ...
... Valeant Pharmaceuticals International, Inc. (the "Company" or "Valeant") ... approved an increase of $300 million under its ... Program").  Under the Securities Repurchase Program, Valeant may ... convertible notes, senior notes, common shares and/or other ...
Cached Medicine Technology:Curemark Reports Positive Results for Novel Compound CM-182 in Amphetamine Induced Hyperactivity 2Valeant Pharmaceuticals Announces Increase to Monetary Limit Under Its Securities Repurchase Program 2Valeant Pharmaceuticals Announces Increase to Monetary Limit Under Its Securities Repurchase Program 3
... maximum positioning flexibility while permitting the components to ... easy transport. The system has a small footprint ... at the same time offers the surgeon total ... camera and display of the Stealthstation Treon can ...
... system for ENT, cranial and spine ... preoperatively, critical zones visible during tracking. ... vision, one button freezes image, snapshot ... Microscope interface: tracks focal point of ...
...
...
Medicine Products: